/

Abridge

Biotech · Pittsburgh, PA · Series C

$213M raised

85

Trust

27

IPO Ready

83

Momentum

IPO Readiness Assessment

27%

✗

CFO Hired+15pts

No CFO identified

✗

General Counsel+10pts

No GC identified

✗

VP Sales / CRO+10pts

No sales leadership identified

✗

Patent Portfolio+8pts

No patents detected

✗

Government Contracts+7pts

No government contracts

✓

Late-Stage Funding+15pts

Currently at series-c

✓

Significant Capital+12pts

$213M raised

✗

Hiring Acceleration+8pts

Normal hiring pace

✗

Team Depth+8pts

Limited team visibility

✗

Recent Fundraise+7pts

No recent funding

Investor Quality

25%

Avg IPO Rate

a16z

Coinbase, Instacart, Okta

28%

IPO rate

VC

Lux Capital

Desktop Metal, Shapeways

15%

IPO rate

VC

Tiger Global

JD.com, Spotify, Roblox

31%

IPO rate

Growth

Executive Team

0 tracked

No team members tracked yet.

Talent Sources

Where this team came from — who they stole from

Limited talent history available. Research task recommended.

Signal History

0 signals

No signals captured yet.